cell < cells < cellular

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 140.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000009 (2008)	Misato Hashizume [Japon] ; Masahiko Mihara [Japon]	Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
000011 (2012)	Emilio Besada [Norvège] ; Johannes C. Nossent [Norvège]	Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab
000017 (2011)	Katsuaki Kanbe [Japon] ; Qian Chen [États-Unis] ; Atsushi Nakamura [Japon] ; Kaori Hobo [Japon]	Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis
000023 (2009)	Misato Hashizume [Japon] ; Yasushi Uchiyama [Japon] ; Naoto Horai [Japon] ; Naohisa Tomosugi [Japon] ; Masahiko Mihara [Japon]	Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
000029 (2011)	Satoru Shinriki [Japon] ; Hirofumi Jono [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Tomoko Ota [Japon] ; Takanao Sueyoshi [Japon] ; Yuichi Oike [Japon] ; Mutsuko Ibusuki [Japon] ; Akimitsu Hiraki [Japon] ; Hideki Nakayama [Japon] ; Masanori Shinohara [Japon] ; Yukio Ando [Japon]	Interleukin‐6 signalling regulates vascular endothelial growth factor‐C synthesis and lymphangiogenesis in human oral squamous cell carcinoma
000035 (2013)	T. Witte [Allemagne]	Methotrexat als Kombinationspartner bei TNF-Inhibitoren und Tocilizumab
000039 (2011)	Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon]	Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders
000052 (2009)	Miho Suzuki [Japon] ; Misato Hashizume [Japon] ; Hiroto Yoshida [Japon] ; Masahiko Mihara [Japon]	Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule
000054 (2016)	Stanislas Faguer [France] ; François Vergez [France] ; Michael Peres [France] ; Inès Ferrandiz [France] ; Audrey Casemayou [France] ; Julie Belliere [France] ; Olivier Cointault [France] ; Laurence Lavayssiere [France] ; Marie-Béatrice Nogier [France] ; Grégoire Prevot [France] ; Antoine Huart [France] ; Christian Recher [France] ; Lionel Rostaing [France]	Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T‐cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis
000069 (2016)	Nozomu Yanaihara [Japon] ; Yukihiro Hirata [Japon] ; Noriko Yamaguchi [Japon] ; Yukiko Noguchi [Japon] ; Misato Saito [Japon] ; Chie Nagata [Japon] ; Satoshi Takakura [Japon] ; Kyosuke Yamada [Japon] ; Aikou Okamoto [Japon]	Antitumor effects of interleukin‐6 (IL‐6)/interleukin‐6 receptor (IL‐6R) signaling pathway inhibition in clear cell carcinoma of the ovary
000103 (2016)	Gustaf Lindgren [Suède] ; Elisabeth Kjellén [Suède] ; Johan Wennerberg [Suède] ; Lars Ekblad [Suède]	Wound‐healing factors can prime head and neck cancer cells to increase their tumor‐forming capacity
000143 (2012)	Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France]	Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
000155 (2009)	Misato Hashizume [Japon] ; Naohiko Hayakawa [Japon] ; Miho Suzuki [Japon] ; Masahiko Mihara [Japon]	IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system
000173 (2013)	Nam Trung Nguyen [Japon, Viêt Nam] ; Taisuke Nakahama [Japon] ; Tadamitsu Kishimoto [Japon]	Aryl hydrocarbon receptor and experimental autoimmune arthritis
000178 (2010)	G. Dückers [Allemagne] ; T. Niehues [Allemagne]	Die Bedeutung von Biologika bei der Therapie der SoJIA (Morbus Still)
000179 (2009)	Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu Kishimoto	Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody
000180 (2009)	Guangjie Chen [République populaire de Chine]	Immunotherapy of Rheumatoid Arthritis Targeting Inflammatory Cytokines and Autoreactive T Cells
000194 (2007)	M. Schneider [Allemagne]	Exploring new territory: considering the future
000212 (2013)	Pierre Gangloff	Biothérapie et odontologie
000227 (2006)	Marcus D. Köller [Autriche]	Targeted therapy in rheumatoid arthritis
000233 (2010)	Hiroshi Kato [États-Unis] ; David A. Fox [États-Unis]	Are Th17 Cells an Appropriate New Target in the Treatment of Rheumatoid Arthritis?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "cells" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "cells" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    cells
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021